SCHEMBL4451101

SCHEMBL4451101

BrCc1cc(Br)c(Br)cc1Br

nearest known ligand 0.36

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 1/20 0.34
ALOX12 P18054 1/20 0.34
AHR P35869 1/20 0.32
PTPN1 P18031 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2268703 0.94 ALOX15 (0.37) ALOX15ALOX12PTPN1
SCHEMBL14933499 0.90 ALOX15 (0.36) ALOX15ALOX12
SCHEMBL10524646 0.87 AHR (0.35) ALOX15ALOX12AHRPTPN1
SCHEMBL16860939 0.78 AHR (0.31) ALOX15ALOX12AHR
SCHEMBL16860902 0.78 DPP4 (0.33) ALOX15ALOX12PTPN1
SCHEMBL2528520 0.78 KDM1A (0.36) ALOX15ALOX12PTPN1
SCHEMBL11847346 0.78 ALDH1A1 (0.39) ALOX15ALOX12
SCHEMBL6827994 0.78 ALOX15 (0.34) ALOX15ALOX12
SCHEMBL10659064 0.78 ALOX15 (0.48) ALOX15ALOX12PTPN1
SCHEMBL10454318 0.77 TDP1 (0.31)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7585912-B2 Flame-retardant polystyrenes BROMINE COMPOUNDS LTD. (IL) 2009-09-08 US claimed
EP-1786853-B1 NOVEL FLAME-RETARDANT POLYSTYRENES BROMINE COMPOUNDS LTD (IL) 2009-04-15 EP claimed
JP-2008506829-A 2008-03-06 JP claimed
US-20070267608-A1 Novel Fire Retardants BROMINE COMPOUNDS LTD. (IL) 2007-11-22 US claimed
US-20070257241-A1 Novel Flame-Retardant Polystyrenes BROMINE COMPOUNDS LTD. (IL) 2007-11-08 US claimed
EP-1786853-A1 NOVEL FLAME-RETARDANT POLYSTYRENES Bromine Compounds Ltd. (IL) 2007-05-23 EP claimed
WO-2006013554-A1 NOVEL FLAME-RETARDANT POLYSTYRENES BROMINE COMPOUNDS LTD. (IL) 2006-02-09 WO claimed
CN-101475433-B Anthryl derivative and preparation thereof HEBEI DELONGTAI CHEMICAL CO., LTD. (CN) 2011-12-07 CN disclosed
CN-101277980-B Process for production of polymer using iron complex as catalyst UNIV KYUSHU NAT UNIV CORP 2010-08-25 CN disclosed
US-7585912-B2 Flame-retardant polystyrenes BROMINE COMPOUNDS LTD. (IL) 2009-09-08 US disclosed
US-7585912-B2 Flame-retardant polystyrenes BROMINE COMPOUNDS LTD. (IL) 2009-09-08 US disclosed
US-7585912-B2 Flame-retardant polystyrenes BROMINE COMPOUNDS LTD. (IL) 2009-09-08 US disclosed
CN-101475433-A Anthryl derivative and preparation thereof HEBEI DELONGTAI CHEMICALS CO L (CN) 2009-07-08 CN disclosed
US-20070257241-A1 Novel Flame-Retardant Polystyrenes BROMINE COMPOUNDS LTD. (IL) 2007-11-08 US disclosed
US-20070257241-A1 Novel Flame-Retardant Polystyrenes BROMINE COMPOUNDS LTD. (IL) 2007-11-08 US disclosed
US-20070257241-A1 Novel Flame-Retardant Polystyrenes BROMINE COMPOUNDS LTD. (IL) 2007-11-08 US disclosed
EP-1786853-A1 NOVEL FLAME-RETARDANT POLYSTYRENES Bromine Compounds Ltd. (IL) 2007-05-23 EP disclosed
EP-1773934-A2 NOVEL FIRE RETARDANTS Bromine Compounds Ltd. (IL) 2007-04-18 EP disclosed
WO-2006013554-A1 NOVEL FLAME-RETARDANT POLYSTYRENES BROMINE COMPOUNDS LTD. (IL) 2006-02-09 WO disclosed
WO-2006006154-A2 NOVEL FIRE RETARDANTS BROMINE COMPOUNDS LTD. (IL) 2006-01-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070267608-A1 Novel Fire Retardants COXFA4, NDUFS5, SQOR ALOX15 2087/4885ALOX12 2802/4885AHR 513/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.